Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4814)
All Articles published online
|
Publishing Process of This Article
|
Dec 7, 2013 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huang YY, Gusdon AM, Qu S. Cross-talk between the thyroid and liver: A new target for nonalcoholic fatty liver disease treatment. World J Gastroenterol 2013; 19(45): 8238-8246 [PMID: 24363514 DOI: 10.3748/wjg.v19.i45.8238] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i45/8238.htm |
| Number | Citing Articles |
| 1 |
Irene O. Aninye, Shunichi Matsumoto, Aniket R. Sidhaye, Fredric E. Wondisford. Circadian Regulation of Tshb Gene Expression by Rev-Erbα (NR1D1) and Nuclear Corepressor 1 (NCOR1). Journal of Biological Chemistry 2014; 289(24): 17070 doi: 10.1074/jbc.M114.569723
|
| 2 |
Hong Lu. Crosstalk of HNF4 α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids. Acta Pharmaceutica Sinica B 2016; 6(5): 393 doi: 10.1016/j.apsb.2016.07.003
|
| 3 |
Maria Mavromati, François R. Jornayvaz. Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD. International Journal of Molecular Sciences 2021; 22(23): 12797 doi: 10.3390/ijms222312797
|
| 4 |
Yuanyuan Liu, Mengjie Wang, Wei Xu, Hongman Zhang, Weihe Qian, Xiang Li, Xingbo Cheng. Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway. Life Sciences 2020; 241: 117086 doi: 10.1016/j.lfs.2019.117086
|
| 5 |
Yan Yang, Jiyuan Xiao, Wen Qiu, Luxia Jiang. Cross-Talk Between Thyroid Disorders and Nonalcoholic Fatty Liver
Disease: From Pathophysiology to Therapeutics. Hormone and Metabolic Research 2024; doi: 10.1055/a-2276-7973
|
| 6 |
V. Prysyazhnyuk. Clinical-pathagenetic, Age, Gender, Genetic Aspects of Non-alcoholic Fatty Liver Disease and Nonviral Chronic Hepatitis Without, and also with Comorbid Hypothyroidism; Improving of Their Treatment. Lviv clinical bulletin 2018; 3(23): 8 doi: 10.25040/lkv2018.03.008
|
| 7 |
Claudia Mandato, Ida D’Acunzo, Pietro Vajro. Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What’s new. Digestive and Liver Disease 2018; 50(11): 1163 doi: 10.1016/j.dld.2018.08.026
|
| 8 |
Ze-Yu Wu, Yi-Ling Li, Bing Chang. Pituitary stalk interruption syndrome and liver changes: From clinical features to mechanisms. World Journal of Gastroenterology 2020; 26(44): 6909-6922 doi: 10.3748/wjg.v26.i44.6909
|
| 9 |
Sara Y. Ngo Tenlep, Megan Weaver, Jianzhong Chen, Olga Vsevolozhskaya, Andrew J. Morris, Cetewayo S. Rashid. Tris(1,3-dichloro-2-propyl) phosphate is a metabolism-disrupting chemical in male mice. Toxicology Letters 2023; 374: 31 doi: 10.1016/j.toxlet.2022.11.021
|
| 10 |
Jing Ya, Yifan Xu, Gang Wang, Hongfeng Zhao. Cadmium induced skeletal underdevelopment, liver cell apoptosis and hepatic energy metabolism disorder in Bufo gargarizans larvae by disrupting thyroid hormone signaling. Ecotoxicology and Environmental Safety 2021; 211: 111957 doi: 10.1016/j.ecoenv.2021.111957
|
| 11 |
Raghu Ramanathan, Sohum A. Patwa, Ahmad Hassan Ali, Jamal A. Ibdah. Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Cells 2023; 12(24): 2806 doi: 10.3390/cells12242806
|
| 12 |
C S Filgueira, E Nicolov, R L Hood, A Ballerini, J Garcia-Huidobro, J Z Lin, D Fraga, P Webb, O M Sabek, A O Gaber, K J Phillips, A Grattoni. Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome. International Journal of Obesity 2016; 40(11): 1776 doi: 10.1038/ijo.2016.129
|
| 13 |
Erin E. Elbel, Joel E. Lavine, Michael Downes, Mark Van Natta, Ruth Yu, Jeffrey B. Schwimmer, Cynthia Behling, Elizabeth M. Brunt, James Tonascia, Ronald Evans. Hepatic Nuclear Receptor Expression Associates with Features of Histology in Pediatric Nonalcoholic Fatty Liver Disease. Hepatology Communications 2018; 2(10): 1213 doi: 10.1002/hep4.1232
|
| 14 |
A. Baranova, D. Maltseva, A. Tonevitsky. Adipose may actively delay progression of NAFLD by releasing tumor‐suppressing, anti‐fibrotic miR‐122 into circulation. Obesity Reviews 2019; 20(1): 108 doi: 10.1111/obr.12765
|
| 15 |
Saliha ACAR, Gıyasettin ÖZCAN, Eyyüp GÜLBANDILAR. Investigation of Genes and Their Interactions in Liver Diseases Using Bioinformatics Algorithms. Gazi University Journal of Science 2024; 37(1): 150 doi: 10.35378/gujs.1182561
|
| 16 |
Amedeo Columbano, Grazia Chiellini, Marta Anna Kowalik. GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease. Gene Expression 2017; 17(4): 265 doi: 10.3727/105221617X14968563796227
|
| 17 |
Rossella Palma, Annamaria Pronio, Mario Romeo, Flavia Scognamiglio, Lorenzo Ventriglia, Vittorio Maria Ormando, Antonietta Lamazza, Stefano Pontone, Alessandro Federico, Marcello Dallio. The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications. Journal of Clinical Medicine 2022; 11(13): 3649 doi: 10.3390/jcm11133649
|
| 18 |
Diana Gataulin, Yael Kuperman, Michael Tsoory, Inbal E Biton, Tomer Nataniel, Raz Palty, Izhar Karbat, Anna Meshcheriakova, Eitan Reuveny, Andrey Abramov. Store-operated Ca2+ entry regulatory factor alters murine metabolic state in an age-dependent manner via hypothalamic pathways. PNAS Nexus 2023; 2(3) doi: 10.1093/pnasnexus/pgad068
|
| 19 |
Viktoriya Bikeyeva, Ahmed Abdullah, Aleksandra Radivojevic, Anas A Abu Jad, Anvesh Ravanavena, Chetna Ravindra, Emmanuelar O Igweonu-Nwakile, Safina Ali, Salomi Paul, Shreyas Yakkali, Sneha Teresa Selvin, Sonu Thomas, Pousette Hamid. Nonalcoholic Fatty Liver Disease and Hypothyroidism: What You Need to Know . Cureus 2022; doi: 10.7759/cureus.28052
|
| 20 |
Liping Lu, Hao Wu, Shixuan Cui, Tingjie Zhan, Chunlong Zhang, Shaoyong Lu, Weiping Liu, Shulin Zhuang. Pentabromoethylbenzene Exposure Induces Transcriptome Aberration and Thyroid Dysfunction: In Vitro, in Silico, and in Vivo Investigations. Environmental Science & Technology 2020; 54(19): 12335 doi: 10.1021/acs.est.0c03308
|
| 21 |
Hee Kyung Kim, Juhyun Song. Hypothyroidism and Diabetes-Related Dementia: Focused on Neuronal Dysfunction, Insulin Resistance, and Dyslipidemia. International Journal of Molecular Sciences 2022; 23(6): 2982 doi: 10.3390/ijms23062982
|
| 22 |
Rohit A. Sinha, Brijesh K. Singh, Paul M. Yen. Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism. Trends in Endocrinology & Metabolism 2014; 25(10): 538 doi: 10.1016/j.tem.2014.07.001
|
| 23 |
P. Charalampoudis, G. Agrogiannis, K. Kontzoglou, G. Kouraklis, G.C. Sotiropoulos. Thyroid hormone receptor alpha (TRa) tissue expression in ductal invasive breast cancer: A study combining quantitative immunohistochemistry with digital slide image analysis. European Journal of Surgical Oncology (EJSO) 2017; 43(8): 1428 doi: 10.1016/j.ejso.2017.05.012
|
| 24 |
Mason T. Breitzig, Matthew D. Alleyn, Richard F. Lockey, Narasaiah Kolliputi. Thyroid hormone: a resurgent treatment for an emergent concern. American Journal of Physiology-Lung Cellular and Molecular Physiology 2018; 315(6): L945 doi: 10.1152/ajplung.00336.2018
|
| 25 |
Roberta D'Ambrosio, Irene Campi, Marco Maggioni, Riccardo Perbellini, Enza Giammona, Roberta Stucchi, Marta Borghi, Elisabetta Degasperi, Annalisa De Silvestri, Luca Persani, Laura Fugazzola, Pietro Lampertico, Pavel Strnad. The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD). PLOS ONE 2021; 16(4): e0249614 doi: 10.1371/journal.pone.0249614
|
| 26 |
Qianyu Tang, Min Zeng, Linxi Chen, Nian Fu. Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.871100
|